JNJ becomes the newest player in CAR-T: http://www.globenewswire.com/news-release/2014/11/24/685872/10109683/en/Transposagen-Biopharmaceuticals-Enters-Into-Research-Collaboration-and-Worldwide-License-Agreement-With-Janssen-for-Allogeneic-Chimeric-Antigen-Receptor-CAR-T-Cell-Therapies.html